参考文献/References:
[1] Weimar C,Kleine-Borgmann J.Epidemiology, prognosis and prevention of Non-Traumatic intracerebral hemorrhage[J].Curr Pharm Des,2017,23(15):2193-2196.[2] 王隆德,刘建民,杨弋,等.我国脑卒中防治仍面临巨大挑战--《中国脑卒中防治报告2018》概要[J].中国循环杂志,2019,34(2):105-119.[3] Shao Z,Tu S,Shao A.Pathophysiological mechanisms and potential therapeutic targets in intracerebral hemorrhage[J].Front Pharmacol,2019,10:1079.[4] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2019)[J].中华神经科杂志,2019,52(12):994-1005.[5] Jadli AS,Ballasy N,Edalat P,et al.Inside(sight)of tiny communicator: exosome biogenesis, secretion, and uptake[J].Mol Cell Biochem,2020,467(1/2):77-94.[6] Chung IM,Rajakumar G,Venkidasamy B,et al.Exosomes: current use and future applications[J].Clin Chim Acta,2020,500:226-232.[7] Skryabin GO,Komelkov AV,Savelyeva EE,et al.Lipid rafts in exosome biogenesis[J].Biochemistry(Mosc),2020,85(2):177-191.[8] Ghoreishy A,Khosravi A,Ghaemmaghami A.Exosomal microRNA and stroke: A review[J].J Cell Biochem,2019,120(10):16352-16361.[9] Abdul-Muneer PM.MicroRNA in the pathophysiology of CNS injury: implication in neuroregenerative medicine[J].CNS Neurosci Ther,2016,22(7):543-545.[10] Matsuyama H,Suzuki HI.Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis[J].Int J Mol Sci,2019,21(1):132.[11] Yu X,Odenthal M,Fries JW.Exosomes as miRNA carriers: Formation-Function-Future[J].Int J Mol Sci,2016,17(12):2028.[12] Kalluri R,Lebleu VS.The biology,function,and biomedical applications of exosomes[J].Science,2020,367(6478): eaau6977.[13] Kong F,Zhou J,Zhou W,et al.Protective role of microRNA-126 in intracerebral hemorrhage[J].Mol Med Rep,2017,15(3):1419-1425.[14] Xi T,Jin F,Zhu Y,et al.MicroRNA-126-3p attenuates blood-brain barrier disruption, cerebral edema and neuronal injury following intracerebral hemorrhage by regulating PIK3R2 and Akt[J].Biochem Biophys Res Commun,2017,494(1/2):144-151.[15] Yang Z,Zhong L,Xian R,et al.MicroRNA-223 regulates inflammation and brain injury via feedback to NLRP3 inflammasome after intracerebral hemorrhage[J].Mol Immunol,2015,65(2):267-276.[16] Zhang X,Gu Y,Li PT,et al.Matrix Metalloproteases-Mediated cleavage on β-Dystroglycan May play a key role in the Blood-Brain barrier after intracerebral hemorrhage in rats[J].Med Sci Monit,2019,25:794-800.[17] Xu F,Shen G,Su Z,et al.Glibenclamide ameliorates the disrupted blood-brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome[J].Brain Behav,2019,9(4):e01254.[18] Xu B,Zhang Y,Du XF,et al.Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity[J].Cell Res,2017,27(7):882-897.[19] Salihu AT,Muthuraju S,Idris Z,et al.Functional outcome after intracerebral haemorrhage-a review of the potential role of antiapoptotic agents[J].Rev Neurosci,2016,27(3):317-327.[20] Zhang H,Wang YZ,Lv Q,et al.MicroRNA-21 overexpression promotes the neuroprotective efficacy of mesenchymal stem cells for treatment of intracerebral hemorrhage[J].Front Neurol,2018,9:931.[21] 赵晓晶,李群喜,刘英,等.美国国立卫生院脑卒中量表评分与脑出血患者预后的相关性探讨[J].中国临床医生杂志,2019,6(6): 712-714.[22] Zhu Y,Wang JL,He ZY,et al.Association of altered serum MicroRNAs with perihematomal edema after acute intracerebral hemorrhage[J].PLoS One,2015,10(7):e0133783.[23] Wang Z,Lu G,Sze J,et al.Plasma miR-124 is a promising candidate biomarker for human intracerebral hemorrhage stroke[J].Mol Neurobiol,2018,55(7):5879-5888.[24] Gallo A,Tandon M,Alevizos I,et al.The majority of microRNAs detectable in serum and saliva is concentrated in exosomes[J].PLoS One,2012,7(3):e30679.[25] 李武英,金俊,陈健,等.脑梗死和脑出血患者外周血中循环microRNA表达谱差异的初步分析[J].实用医学杂志,2014,30(11):1750-1753.[26] Spaull R,Mcpherson B,Gialeli A,et al.Exosomes populate the cerebrospinal fluid of preterm infants with post-haemorrhagic hydrocephalus[J].Int J Dev Neurosci,2019,73(1):59-65.[27] Li L,Wang PP,Zhao HP,et al.Noncoding RNAs and intracerebral hemorrhage[J].CNS Neurol Disord Drug Targets,2019,18(3):205-211.[28] Desantis V,Saltarella I,Lamanuzzi A,et al.MicroRNAs-Based Nano-Strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance[J].Int J Mol Sci,2020,21(9):3084.[29] Scheideler M,Vidakovic I,Prassl R.Lipid nanocarriers for microRNA delivery[J].Chem Phys Lipids,2020,226:104837.[30] Ha D,Yang NN,Nadithe V.Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges[J].Acta Pharm Sin B,2016,6(4):287-296.[31] Samanta S,Rajasingh S,Drosos N,et al.Exosomes: new molecular targets of diseases[J].Acta Pharmacol Sin,2018,39(4):501-513.[32] Rufino-Ramos D,Albuquerque PR,Carmona V,et al.Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases[J].J Control Release,2017,262:247-258.[33] Shen H,Yao XY,Li HY,et al.Role of exosomes derived from miR-133b modified MSCs in an experimental rat model of intracerebral hemorrhage[J].J Mol Neurosci,2018,64(3):421-430.